Lundbeck
HLUN-B.CO
#2496
Rank
โ‚น500.13 B
Marketcap
โ‚น523.05
Share price
0.98%
Change (1 day)
25.80%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น30.61. In 2022 the company made an earnings per share (EPS) of โ‚น23.28 a decrease over its 2021 EPS that were of โ‚น52.28.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0124.64%
2022โ‚น23.28-55.47%
2021โ‚น52.28-51.83%
2020โ‚น108.52-28.01%
2019โ‚น150.73-44.08%
2018โ‚น269.5551.94%
2017โ‚น177.40126.64%
2016โ‚น78.27-120.84%
2015-โ‚น375.625622.18%
2014-โ‚น6.56-110.03%
2013โ‚น65.42-28.08%
2012โ‚น90.97-52.1%
2011โ‚น189.90-1.31%
2010โ‚น192.4315.61%
2009โ‚น166.44